The interaction between acetylcholinesterase (EC 3.1.1.7) and heparin, a sulphated glycosaminoglycan, was studied by affinity chromatography. A specific binding of the asymmetric acetylcholinesterase to an agarose gel containing covalently bound heparin was demonstrated. This interaction required an intact collagenous tail, shown by the fact that the binding is abolished by pretreatment with collagenase. The globular forms did not bind to the column. Both total and intracellular asymmetric acetylcholinesterase forms isolated from the endplate region of the rat diaphragm muscle showed higher affinity for the heparin than did the enzyme from the nonendplate region. The binding to the resin was destabilized with 0.55M-NaCl, and, among the various glycosaminoglycans tested, only heparin was able to displace the acetylcholinesterase bound to the column. Our results added further support to the concept that the asymmetric acetylcholinesterase forms are immobilized on the synaptic basal lamina via interactions with heparin-like molecules, probably related to heparan sulphate proteoglycans.
The interaction between acetylcholinesterase (EC 3.1.1.7) and heparin, a sulphated glycosaminoglycan, was studied by affinity chromatography. A specific binding of the asymmetric acetylcholinesterase to an agarose gel containing covalently bound heparin was demonstrated. This interaction required an intact collagenous tail, shown by the fact that the binding is abolished by pretreatment with collagenase. The globular forms did not bind to the column. Both total and intracellular asymmetric acetylcholinesterase forms isolated from the endplate region of the rat diaphragm muscle showed higher affinity for the heparin than did the enzyme from the nonendplate region. The binding to the resin was destabilized with 0.55M-NaCl, and, among the various glycosaminoglycans tested, only heparin was able to displace the acetylcholinesterase bound to the column. Our results added further support to the concept that the asymmetric acetylcholinesterase forms are immobilized on the synaptic basal lamina via interactions with heparin-like molecules, probably related to heparan sulphate proteoglycans.
Acetylcholinesterase (AChE) is highly concentrated at the neuromuscular junction, where it plays an essential role in synaptic transmission by rapidly removing, through hydrolysis, the acetylcholine released into the synaptic cleft from presynaptic nerve terminals (Kuffler & Nicholls, 1979) . The different AChE molecules may be classified as globular forms (monomers GI, dimers G2 and tetramers G4) and asymmetric forms (containing one, two or three tetramers, plus a collagen-like tail: A4, A8 and A12) (Massoulie & Bon, 1982) . In rat and mouse muscles the enzyme forms that are concentrated at the neuromuscular junction are the asymmetric forms of AChE (Hall, 1973; Inestrosa et al., 1982) . These forms would be anchored to the basal lamina by the collagen-like tail Bon et al., 1979; Inestrosa et al., 1982) . The basal lamina is an extracellular coat of collagen, glycoproteins and proteoglycans (Sanes, 1982; Yamada, 1983 ) that has been implicated in both pre-and post-synaptic differentiation (Sanes, 1983) . This lamina surAbbreviations used: AChE, acetylcholinesterase (EC 3.1.1.7); Echothiophate, S-[2-(NNN-trimethylammonio)ethylj-OO-diethylphosphorothioate iodide.
* To whom correspondence should be addressed.
rounds each muscle fibre, extending through the synaptic cleft . It has been suggested that the association of the asymmetric AChE with glycosaminoglycans and fibronectin may serve to bind the enzyme to the basal lamina (Massoulie & Bon, 1982) . Recent studies from our laboratory have shown that heparin, a sulphated glycosaminoglycan, specifically solubilizes the collagen-tailed AChE from endplate regions of the rat muscle and from the rat peripheral nerve .
We have studied the binding of the different AChE forms to heparin-agarose by means of affinity chromatography. Our studies show that only the asymmetric forms of AChE bind to the heparin column and that such binding is dependent on the tail structure. We also find a higher binding of asymmetric AChE obtained from the endplate region compared with that from the nonendplate region. Furthermore, we have characterized the properties of the binding using asymmetric AChE from Discopyge electric organ. The results indicated that the binding is strong and homogeneous and that among various glycosaminoglycans only heparin is able to displace the AChE bound to the column.
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Experimental

Animals
The experiments were carried out on male Sprague-Dawley rats (100-250g body wt.) and on Discopyge tschudii, a fish of the Torpedinidae Family (Inestrosa & Mendez, 1983) .
Dissection of rat diaphragm muscle
Rat diaphragm muscle, together with attached ribs, was removed, washed in ice-cold saline (0.9% NaCl), rapidly cleaned of most of the connective tissue and then the muscle separated from the ribs. The diaphragm was divided into regions containing endplates and those without endplates, by cutting a 2-3mm strip of muscle alongside the nerve under a dissecting microscope (Hall, 1973; Inestrosa et al., 1982; ).
Extraction of AChE activity Rat muscle diaphragm. The endplate and nonendplate regions were homogenized in 10mM-Tris/ HCI buffer, pH 7.4, containing 20 units of aprotinin/ml, 1 mM-benzamidine and 5 mM-EDTA. The homogenate was centrifuged in a Sorvall SS-34 rotor at 15 OOOg for 15 min at 40C. This supernatant was the source of globular forms of AChE (Bon et al., 1979) . The pellet was resuspended in the same homogenization medium plus 0.5% (v/v) Triton X-100 and centrifuged again. The resulting pellet was resuspended in lOmM-Tris/HCl buffer, pH7.4, containing 20 units of aprotinin/ml, 1 mM-benzamidine, 5mM-EDTA and 1.OM-NaCl and centrifuged at 15OOOg for 15min. The supernatant, containing the asymmetric forms of AChE, was dialysed against lOOOvol. of lOmM-Tris/HCl buffer, pH 7.4, containing 0.1 M-NaCl for 3 h at 4°C. The non-diffusible material was centrifuged as above. The pellet was resuspended in lOmM-Tris/ HCI buffer, pH7.4, containing 0.2M-NaCl. This was the source of asymmetric forms of AChE.
Electric organ of Discopyge. Electric organ was dissected out and kept frozen at -80°C. The tissue was homogenized in 10mM-Tris/HCI buffer, pH 7.4, containing 20 units of aprotinin/ml, 1 mMbenzamidine, 5mM-EDTA, 0.500 (v/v) Triton X-100 and O.1M-6-aminohexanoic acid. The homogenate was centrifuged in an SS-34 rotor at 15 OOOg for 15 min at 40C. The pellet was rehomogenized in the same medium and centrifuged again. This step was repeated four times. The last pellet was resuspended in the same medium as above plus 1.OM-NaCl. The mixture was centrifuged as before and the supernatant contains a crude fraction of asymmetric forms of AChE.
Selective inhibition of external AChE from rat diaphragm muscle
In order to inactivate external AChE, the method described by Younkin et al. (1982) was used. In brief, diaphragms detached from the ribs were immersed in cold phosphate-buffered saline (1 50mM-NaCl/lOmM-sodium phosphate buffer, pH 7.4) containing 1.25 uM-Echothiophate (an impermeable and irreversible inhibitor of the AChE) for 20min at 4°C. Then the muscle were rinsed several times with cold phosphate-buffered saline, and endplate and non-endplate regions were dissected out as described above.
Sedimentation analysis of AChE
The different molecular forms of AChE were separated by sedimentation on linear sucrose gradients (Inestrosa et al., 1979 (Inestrosa et al., , 1981 . A Hoeffer gradient-former was used. Linear sucrose gradients (5-20%, w/v) in 50mM-Tris/HCI buffer, pH7.4, and containing 5mM-EDTA, 1.OM-NaCl and 0.5% (v/v) Triton X-100 were used. A 200!d sample was layered on the top of the gradient, and centrifugation was performed in a Beckman SW65 rotor at 215 OOOg for 7.5h at 4°C in a Beckman L5-65 ultracentrifuge. Fractions were collected from the bottom of the gradient and assayed for AChE activity. Sedimentation coefficients for AChE forms were estimated by comparison with that for P-galactosidase (16.1S) measured as described by Craven et al. (1965) .
Binding of AChE to heparin affinity column
The globular or asymmetric forms of AChE were applied to a heparin-agarose column (0.3cmx2.0cm) containing 0.4ml of resin preequilibrated with l0mM-Tris/HCl buffer, pH7.4, containing 0.2M-NaCl. The columns were washed extensively with the same buffer, and the bound AChE was eluted with lOmM-Tris/HCl buffer, pH7.4, containing 1.OM-NaCl. When fractions obtained from the sucrose gradients were used, bovine serum albumin (2.0mg/ml) was included in all the solutions. In some experiments the bound AChE was eluted with different glycosaminoglycans, the conditions of which are specified in the legends to the corresponding Figures.
Treatment with collagenase and heparinase Treatment with collagenase. Asymmetric forms of AChE were digested with highly purified collagenase from Clostridium histolyticum (Sigma type VI). In brief, asymmetric forms of AChE were incubated with 22 units of collagenase in the presence of lOOmM-Tris/HCI buffer pH7.2, containing 7.5 mM-CaCl, for 1 h at 37°C. When EDTA was present the concentration used was 7.5mM.
Treatment with heparinase. Heparin-agarose resin was incubated for 20h with 1.2mg of heparinase/ ml in 10mM-Tris/HCl buffer, pH7.4, containing 0.15M-NaCl and 2.0mg of bovine serum albumin/ ml at room temperature. Then the resin was washed with high-ionic-strength buffer, pre-equilibrated with the same buffer as above and the AChE-binding capacity evaluated.
AChE assay
AChE activity was measured by the method of Ellman et al. (1961) . The determinations were done in a 1.0ml of reaction mixture containing 100mM-sodium phosphate buffer, pH7.0, 0.75mM-acetylthiocholine iodide and 0.3mM-5,5'-dithiobis-(2-nitrobenzoic acid). Hydrolysis of acetylthiocholine by the samples was decreased at least 95% by the addition of lO4uM-compound BW284c51, a selective AChE inhibitor. One unit of AChE activity is equal to 1.0umol of substrate breakdown/min at 37°C in the above conditions. Reagents
The following chemicals Fig. 1 shows the chromatographic profiles of the globular ( Fig. la) and asymmetric ( Fig. lb) preparations from the endplate regions of rat diaphragm muscle, eluted from an heparinagarose affinity column. Most (80%) of the asymmetric forms bound to the column were released by heparin; the remaining 20% required high ionic strength (1.0M-NaCl) to be eluted. Of the total asymmetric AChE forms applied to the column, 50-60% of the activity was bound, and this value was not changed by increasing the column size 5-fold; moreover, when the unbound asymmetric AChE was re-applied to the column, no further binding was observed. This suggests that the asymmetric AChE forms can exist in different states, i.e. 'binding' and 'non-binding' species of the enzyme. In order to show the specificity of the column, a mixture of both globular and asymmet- ric AChE preparations was run through the heparin column, and both the applied enzyme and the AChE forms eluted by heparin were analysed in a linear 5-20% sucrose gradient. Fig. 2 shows the sedimentation pattern of the AChE molecular forms loaded on the column (Fig. 2a) and the forms released by heparin (Fig. 2b) The asymmetric forms of AChE are concentrated at the endplate region of skeletal muscles (Hall, 1973) . However, as established by Younkin et al. (1982) , they are also found in the non-endplate regions. In order to compare the relative affinities of both pools of asymmetric forms for the heparinagarose column, we tested fractions of endplate and non-endplate asymmetric forms for binding to the heparin-agarose column. Table 2 shows a higher relative affinity of the asymmetric AChE from the endplate region, as compared with that from non-endplate region, for the heparin-agarose. Because at the endplate region most of the asymmetric AChE corresponds to external AChE (Younkin et al., 1982) , we measured the binding capacity of the intracellular pool ofAChE. For this purpose, we inactivated the external AChE from both the endplate and the non-endplate regions, using the impermeable inhibitor of AChE, Echothiophate (Inestrosa, 1984) , and then worked with the residual asymmetric forms of AChE. No differences in binding capacity as compared with the total AChE was found, when the internal pool of AChE from both regions was applied to the column (Table 2 ). Since globular forms did not bind to the column, we wanted to know whether the differences in binding detected between endplate and non-endplate asymmetric forms was due to contamination of the non-endplate fraction with globular forms. Table 3 shows the distribution of the molecular forms ofboth samples; it is clear that the amount of globular AChE forms present in both regions is similar, and therefore we cannot attribute the differences observed in binding to contamination by globular forms of the nonendplate fractions. Therefore the only apparent difference between the endplate and non-endplate asymmetric enzymes, namely the different proportions of intra-and extra-cellular pools do not explain their observed differences in binding to the column.
1984 Table 1 . Effect of collagenase and heparin on the binding of asymmetric AChE to heparin-agarose For the collagenase treatment, asymmetric forms from either endplate region of diaphragm or electric organ were digested with 22 units of purified collagenase in the presence of lO0mM-Tris/HCl buffer, pH7.2, containing 7.5mM-CaCl2 for 1 h at 370C. Controls were incubated in presence of 7.5 mM-EDTA and without CaCl2; no effect on the binding was seen in either case. After the incubation, the mixture was loaded on the heparin-agarose column and the activity eluted was collected and measured as described in the text. For the heparin treatment, asymmetric forms were loaded in a column pre-equilibrated with 2.0mg of heparin, and fractions were collected and AChE activity measured as indicated for the collagenase-treated functions. Binding is expressed as the percentage in each fraction of the total AChE activity recovered. Collagenase had no effect on AChE activity. The The activity unbound to the heparin-agarose column corresponded to the activity that was eluted with lOmM-Tris/HCl buffer, pH7.4, containing 0.2M-NaCl, and the bound activity to that which was eluted with lOmM-Tris/HCl buffer, pH 7.4, containing l.OM-NaCl. The recoveries of the AChE activity were in the range 85-95%. Values shown in the Table 2 legend. Portions of these samples (total AChE) were loaded on a sucrose gradient (5-20%) in 50mM-Tris/HCI buffer, pH8.4, containing 5mM-EDTA, 1.OM-NaCl and 0.5% Triton X-100. The gradients were run at 215000g for 7.5h in a Beckman SW65 rotor at 4°C. Gradients were fractionated and AChE assayed as indicated in Fig. 2 Fig. 3 shows the curve resulting when the AChE activity is loaded at different ionic strengths (Fig. 3 , *-@) or when activity loaded in 0.2M-NaCl was eluted with different ionic strengths (Fig. 3, O--O) . The results show that the binding of 16S AChE to the heparin-agarose column is strong. In fact, half of the AChE activity was still bound at 0.55M-NaCl. The Figure also shows that at 0.5M-NaCl 75% of the AChE was bound, but at 0.6M only 10% of the activity column remained bound. The fact that the destabilization of the binding of AChE to the heparin-agarose [NaCIl (M) (Hayashi & Yamada, 1982 ) that fibronectin is able to bind heparin, and that such a binding is influenced by bivalent cations. In order to test if any effect of bivalent cations could be detected in the binding of the 16S AChE to heparin-agarose, we loaded different columns with electric-organ 16S AChE in presence of lOmM-MgCl2, -CaCl2 or -EDTA. In other experiments the enzyme was allowed to bind to the heparin-agarose column, and then it was eluted with the different cations or with EDTA. No effect on the binding or on the eluted activity was found in any of the conditions tested (results not shown).
As a control of the binding, we incubated the heparin-agarose with crude heparinase, in order to see how this treatment affects the binding of the enzyme to the column. The results are shown in the Table 4 . The treatment of the resin with heparinase at the concentration used decreased the binding of the 16S AChE to the column to 30% of that obtained with the untreated resin. This result clearly indicates that the binding of the enzyme depends on the heparin attached to the agarose. Similar results were found when AChE from rat diaphragm was used. Fig. 3 . Effect ofionic strength on the binding of 16S AChE from Discopyge to heparin-agarose columns Different columns were pre-equilibrated with lOmM-Tris/HCl buffer, pH 7.4, containing 2.0mg of bovine serum albumin/ml and NaCl at the concentrations indicated (0). A 0.14 unit portion of 16S AChE from Discopyge were loaded on each column and washed with 1Ovol. ofthe same buffer. Then the columns were washed with lOvol. of lOmM-Tris/ HCI buffer, pH7.4, containing 2.0mg of bovine serum albumin/ml and 1.OM-NaCl and the activities were assayed by the method of Ellman et al. (1961) . Each point in the Figure was calculated as 100 x the activity eluted by 1.OM-NaCl divided by the total activity recovered. In the curve (0), all the columns were pre-equilibrated with lOmM-Tris/HCl buffer, pH 7.4, containing 2.0mg of bovine serum albumin/ ml and 0.2M-NaCl, and the columns were loaded with 0.14 unit of 16S AChE from Discopyge and washed with buffer containing NaCl at the indicated concentrations. After that, the columns were washed with lOmM-Tris/HCl buffer, pH7.4, containing 2.0mg of bovine serum albumin/ml and 1.OM-NaCI in order to remove all the AChE still bound to the column. The activity was calculated as 100 x the activity eluted by the buffer containing NaCl at different concentrations divided by the total AChE activity recovered. The recoveries in both experiments were in the range 78-90% of the loaded AChE activity. Heparin-agarose (0.3 ml) was incubated for 20h, at the temperature indicated, in the presence of bovine serum albumin (2.Omg/ml). Heparinase, when present, was at a concentration of 1.2mg/ml. After the incubation the resin was poured into columns (0.4cm x 2.0cm) and washed with 20vol. of 10mM-Tris/HCI buffer, pH7.4, containing 2.0mg of bovine serum albumin/ml and I.OM-NaC1. Then the columns were pre-equilibrated with 20vol. of lOmM-Tris/HCI buffer, pH7.4, containing 2.0mg of bovine serum albumin/ml and 0.2M-NaCl. Then 0.12 unit of 16S AChE from Discopyge was loaded on each column. The activity that was eluted in these conditions was the unbound AChE activity, and the bound activity corresponded to the activity that was eluted with lOmM-Tris/HCI buffer, pH 7.4, containing 2.0mg of bovine serum albumin/ml and 1.OM-NaCl. Heparin displaces the bound AChEfrom the heparinagarose column Since it has been shown that proteins bound to glycosaminoglycans can sometimes be displaced by other polysaccharides, we studied the effect of glycosaminoglycans in the elution buffer on the binding of the enzyme to the heparin-agarose column. For this, different columns were loaded with 16S AChE from Discopyge, and eluted with different concentrations of heparin, chondroitin sulphate or hyaluronic acid. The results are shown in Fig. 4(a) . Only heparin was able to displace the AChE bound to the column. It may be noted that the shape of the curve and the range of concentrations at which heparin displaced the enzyme from the column were similar to those found when heparin was used to release AChE from endplate region or electric-organ homogenates (Brandan et al., 1983) . No effect of the glycosaminoglycans employed on the AChE activity was involved, since almost all the bound AChE was recovered after elution with high-ionic-strength buffer (Fig.   4(b) , compare (i) with (ii)].
Discussion
We have shown in the present work that the asymmetric forms, but not the globular forms, of AChE were able to bind to heparin-agarose columns. The asymmetric forms of AChE have a collagen-like tail and are sensitive to collagenase (Bon etal., 1979) . The binding was abolished when the asymmetric forms were treated with collagenase. This result suggests that the tail participates directly in the binding of the enzyme to the glycosaminoglycan. In view of our studies showing that heparin specifically solubilizes synaptic forms of AChE ) and the neural 16S AChE , we have suggested that heparin might be competing with components of the muscle basal lamina, such as heparan sulphate proteoglycans, for binding sites on the collagenous tail of the asymmetric AChE. Furthermore, only heparin was able to release specifically the AChE bound to the column, for the enzyme obtained from both the endplate muscle regions and the electric organ. Therefore our studies strongly support the concept that a heparin sulphate proteoglycan is involved in the immobilization of the collagen-tailed AChE to the basal lamina of the neuromuscular junction.
Our results revealed that 90-95% of 16S AChE from electric organ is able to bind to heparinagarose, compared with only a 65% of the asymmetric AChE of mammalian muscle. On the basis of such a difference we can offer some possible explanations: higher sensitivity to proteolytic damage of the muscle asymmetric forms as compared with the electric-organ enzyme. Although we used proteinase inhibitors in all the steps of the fractionation procedure, this possibility cannot be dismissed. Another possible explanation is the presence in the muscle extracts of other AChE-binding factors, which would decrease the actual amount of AChE available to bind to the column. A third possible explanation may be that the muscle contains a heterogeneous population of asymmetric forms of AChE with regard to their capacity to bind to the resin.
Another finding of this work that should be noted was the fact that the asymmetric AChE from Vol. 221 the endplate region showed higher affinity for the heparin-agarose resin than did the enzyme obtained from the non-endplate region. Since both preparations of enzyme contain similar proportions of globular forms, which do not bind to the column, then this difference should be related to some feature of the asymmetric pools of both regions.
Previous reports have strongly suggested that the asymmetric forms ofAChE are concentrated at the neuromuscular junction in close association with the basal lamina (Bon et al., 1979) . However, it is not clear which are the molecules involved in the anchorage of the asymmetric AChE to the basal lamina. It has been suggested that the enzyme is associated with chondroitin sulphate (Bon et al., 1978) , fibronectin (Emmerling et al., 1981) , laminin, collagen type V and heparan sulphate (Vigny et al., 1983 ). However, a recent report (Grassi et al., 1983) has shown the absolute absence of binding of laminin, fibronectin and collagen type V to the asymmetric AChE. Unfortunately, the binding to heparan sulphate proteoglycans was not studied. However, in view of our previous work Brandan et al., 1983 ) and the results given in the present paper, the relation between the asymmetric AChE and a heparin-like proteoglycan may turn out to be physiologically important.
Lipoprotein lipase is an enzyme that can be released from its anchorage sites by heparin (Olivecrona et al., 1977) , and it has been shown that it binds to heparin-Sepharose (Olivecrona et al., 1971) . Moreover, Williams et al. (1983) (Farquhar, 1981) .
